Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Optasia Medical was a medical technology company that developed computer-aided detection (CAD) software for the musculoskeletal market. Its primary product, ASPIRE, was designed to automate the detection of vertebral fractures in X-ray and DXA images, facilitating the early diagnosis of osteoporosis. The company's technology aimed to improve clinical workflow and diagnostic accuracy for radiologists and clinicians. In 2011, Optasia Medical was acquired by Hologic, a global leader in women's health, to enhance its skeletal health product portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Optasia Medical.